Dean Harvey Comments on Valeant-Kadmon Pharma Antitrust Challenges

Dean Harvey Comments on Valeant-Kadmon Pharma Antitrust Challenges

Reuters has published a compelling analysis of ongoing challenges facing pharmaceutical “rogue” Valeant with a focus on its price-inflated drug Syprine and its relationship with also-beleagured pharma company Kadmon. Among other issues, Valeant has been singled out as a prime offender in the realm of hyper-inflated pharmaceutical drugs, with, Syprine, its life-saving Wilson’s disease liver ailment treatment costing some patients nearly $300,000 for a year’s use (in 2011, Valeant priced the drug at less than $1,000 for 100 capsules, a rate that rose by 2015 to over $21,000 for the same dose). [Read more…]

Dean Harvey on the 5 Writing Mistakes Antitrust Lawyers Should Avoid

Dean Harvey on the 5 Writing Mistakes Antitrust Lawyers Should Avoid

Lieff Cabraser partner Dean M. Harvey spoke with Law360 to offer advice to antitrust lawyers on “five writing mistakes that can tilt the balance against your antitrust clients.” Along with Hausfeld LLP’s Scott Martin and Daniel Francis of Hunton & Williams, Mr. Harvey was tapped by the legal journal for his knowledge and expertise in the face of an inherent problem for antitrust attorneys created by “the complexity of competition law [which] puts them at a heightened risk of hurting their chances of victory by writing briefs that judges struggle to read.” [Read more…]

Dean Harvey Provides Tips For Aspiring Antitrust Lawyers

Dean Harvey Provides Tips For Aspiring Antitrust Lawyers

Lieff Cabraser partner Dean Harvey provided a wealth of useful content to Law360‘s recent article, “5 Career Tips For Aspiring Antitrust Lawyers.” The piece, which seeks to instruct fledgling competition attorneys on developing their skill set, contains numerous tips and guidelines for mastering antitrust law and carving out a practice aimed at becoming “a top-tier antitrust practitioner.” [Read more…]

Bruce Leppla to Speak at the Investment Company Institute 2016 General Meeting

Bruce Leppla to Speak at the Investment Company Institute 2016 General Meeting

Lieff Cabraser attorney Bruce W. Leppla will be speaking at the Investment Company Institute’s May 19, 2016 General Meeting on “Non-Traditional Approaches to Antitrust and Securities Litigation.” Mr. Leppla and his partners represent institutional investors in investment loss recovery in circumstances where such losses are due to fraud or serious corporate misconduct. He will discuss the Credit Default Swap and Foreign Exchange (FX) antitrust litigation as well as creative legal approaches that have been used to resolve securities opt-out litigation matters. As one Lieff Cabraser client said, “the days of leaving money on the table are over.” [Read more…]

Defendants’ Motions to Dismiss Denied in Duke/UNC “No Hire” Agreement Employee Wage Suppression Litigation

Antitrust

Lieff Cabraser represents Danielle M. Seaman, M.D., in a class action lawsuit against Duke University; Duke University Health System; and Dr. William L. Roper, Dean and Vice-Chancellor of Medical Affairs for University of North Carolina at Chapel Hill School of Medicine, and Chief Executive Officer of the University of North Carolina Health Care System. The complaint charges that the defendants entered into an express, secret agreement not to hire each other’s faculty, with the intent and effect of suppressing the mobility and pay of each other’s skilled medical employees. [Read more…]

Lasting Effects of the Silicon Valley No-Poach Case Spread

High-Tech No Poach Case

According to The Recorder, “The groundbreaking [High-Tech Antitrust] class action, one of the first to successfully apply antitrust law to employment activity, has ushered in a wave of similar suits targeting California animation studios, North Carolina medical schools, a mixed martial arts promoter and additional tech companies.” [Read more…]

Dean Harvey to Discuss Future of Antitrust Enforcement at American Antitrust Institute Young Lawyers Breakfast

Dean Harvey Discusses Future of Private Antitrust Enforcement

Lieff Cabraser partner Dean M. Harvey will participate in a panel discussion titled “The Future of Private Antitrust Enforcement” at the American Antitrust Institute’s (AAI) Young Lawyers Breakfast on November 18, 2015. [Read more…]

FIFA Bribery Scandal & Potential For Private Lawsuits

FIFA Bribery Scandal & Potential For Private Lawsuits

On May 27, 2015, the U.S. Attorney’s Office for the Eastern District of New York announced a 47-count indictment charging nine FIFA officials and five corporate executives with a vast, 24-year scheme to “enrich themselves through the corruption of international soccer.” Soccer officials solicited and received over $150 million in bribes from sports marketing companies in return for lucrative marketing rights — including television and radio broadcasting rights, advertising rights, sponsorship rights, licensing rights, hospitality rights, and ticketing rights — to FIFA events and matches.

[Read more…]

Dean Harvey Speaks at ABA Business Torts & Civil RICO Committee Town Hall Meeting

Dean Harvey Speaks at ABA Business Torts & Civil RICO Committee Town Hall Meeting

The American Bar Association (ABA) Section of Antitrust Law Business Torts & Civil RICO Committee (BTCR) presents a Town Hall Meeting on December 15, 2014. Lieff Cabraser attorney Dean M. Harvey will be featured as a panelist in a discussion about the committee’s mission, leadership, and volunteer opportunities.

[Read more…]